Resilience US, Inc.

Form 483

Issued to: Amylin Pharmaceuticals Inc.

West Chester, Ohio, United StatesFEI 3006316363Issued July 23, 2015

View Form 483 PDF

Source: FDA, document on file. FDA released the Form 483 itself. The document linked above is our copy of FDA's file, stored by us so the link cannot break, and FDA's own copy is linked beside it. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3006316363.

Observations10

Issue DateJuly 23, 2015

StatusNo Warning Letter

Establishment TypePharmaceutical Manufacturer

Related Inspections10

Establishment Details

Firm: Resilience US, Inc.
Issued To: Amylin Pharmaceuticals Inc.
Location: West Chester, Ohio, United States
FEI Number: 3006316363
Establishment Type: Pharmaceutical Manufacturer
Product Type: Drugs
Issue Date: July 23, 2015
Country: United States

Inspection History, 2013 to 2025

NAI7

VAI3

NAI means No Action Indicated. VAI means Voluntary Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Resilience US, Inc. FDA Form 483, West Chester, Ohio, July 23, 2015